Jason Wittes Analyst PerformanceAnalyst at Roth CapitalJason Wittes is a stock analyst at Roth Capital focused in the medical sector, covering 27 publicly traded companies. Over the past year, Jason Wittes has issued 10 stock ratings, including strong buy and buy recommendations. While full access to Jason Wittes' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Wittes' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings118 Last 10 YearsBuy Recommendations81.36% 96 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution118RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Wittes.RatingPercentageCount Strong Buy0.8%1 ratings Buy80.5%95 ratings Hold15.3%18 ratings Sell3.4%4 ratingsOut of 118 total stock ratings issued by Jason Wittes at Roth Capital, the majority (80.5%) have been Buy recommendations, followed by 15.3% Hold, 3.4% Sell, and 0.8% Strong Buy.Best & Worst CallsBest Call0000.0%LMATJul 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%XTNTMar 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.0% of companies on NASDAQ17 companiesNYSE29.6% of companies on NYSE8 companiesNYSEAMERICAN3.7% of companies on NYSEAMERICAN1 companyOTCMKTS3.7% of companies on OTCMKTS1 companyJason Wittes, an analyst at Roth Capital, currently covers 27 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical23 companies85.2%Miscellaneous2 companies7.4%Manufacturing1 company3.7%Computer and Technology1 company3.7%Jason Wittes of Roth Capital specializes in stock coverage within the Medical sector, with additional focus on and Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS7 companies25.9%MED PRODUCTS6 companies22.2%MED - BIOMED/GENE4 companies14.8%MED - DRUGS2 companies7.4%Miscellaneous2 companies7.4%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company3.7%MEDICAL DEVICES1 company3.7%INSTRUMENTS TO MEASURE ELECTRICITY1 company3.7%ELECTROMEDICAL EQUIPMENT1 company3.7%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company3.7%SURGICAL APPLIANCES & SUPPLIES1 company3.7% Jason Wittes' Ratings History at Roth Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSPRYARS Pharmaceuticals9/4/2025Initiated Coverage$10.88$40.00Buy$0.0000.00% ROICVCapsoVision7/28/2025Set Price Target$4.00$6.00Buy$0.0000.00% ROICVCapsoVision7/28/2025Upgrade$4.35$6.00Strong-Buy$0.0000.00% ROISYKStryker5/2/2025Boost Price Target$377.63$456.00Buy$0.0000.00% ROIALURAllurion Technologies3/21/2025Reiterated Rating$3.17$16.00Buy$0.0000.00% ROIMGRMMonogram Orthopaedics3/18/2025Boost Price Target$3.62$5.40Buy$0.0000.00% ROIFBIOFortress Biotech3/11/2025Reiterated Rating$1.75$16.00Buy$0.0000.00% ROIOFIXOrthofix Medical2/26/2025Reiterated Rating$17.07$22.00Buy$0.0000.00% ROIIRMDiRadimed2/14/2025Reiterated Rating$55.53$72.00Buy$0.0000.00% ROITLSITriSalus Life Sciences1/24/2025Reiterated Rating$5.17$11.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
